CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BiomX Inc.

PHGE
$63M
Micro Cap
NASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaDOVER

Drugs in Pipeline

2

Phase 3 Programs

0

Upcoming Catalysts

1

Next Catalyst

Aug 12, 2026

5w

Market Overview

Stock performance and key metrics

PHGE News
Catalyst Timeline

1 upcoming, 0 past

How PHGE's past catalysts played out

Drug Pipeline
Market-Implied Move
Regulatory Approvals

Frequently asked questions

What is in BiomX Inc.'s drug pipeline?

CatalystAlert tracks 2 drug candidates in BiomX Inc.'s (PHGE) pipeline across Phase 2. Its lead program is BX004-A (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is BiomX Inc.'s next FDA catalyst?

BiomX Inc.'s (PHGE) next tracked catalyst is a Earnings expected August 12, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track PHGE biotech catalysts?

Add PHGE to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow BiomX Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply